查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2028 年全球单纯疱疹病毒治疗市场规模、份额和行业趋势分析报告按药物类型、类型、分销渠道和地区分列的展望和预测
市场调查报告书
商品编码
1261387

2022-2028 年全球单纯疱疹病毒治疗市场规模、份额和行业趋势分析报告按药物类型、类型、分销渠道和地区分列的展望和预测

Global Herpes Simplex Virus Treatment Market Size, Share & Industry Trends Analysis Report By Drug Type, By Type, By Distribution Channel, By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 209 Pages | 订单完成后即时交付

价格

单纯疱疹病毒治疗市场规模预计到 2028 年将达到 21 亿美元，预计在预测期内将以 3.0% 的复合年增长率增长。

唇疱疹通常没有症状，但有时会在口腔内和周围引起疼痛的水泡和溃疡。 此外，在口腔溃疡形成之前，感染者通常会感到口腔周围疼痛、发热或发痒。 这些復发的频率因人而异。

中度和无症状的生殖器疱疹病例常常被忽视。 当生殖器疱疹症状首次出现时，会出现一个或多个肛门或生殖器溃疡或水疱。 发烧、身体疼痛和淋巴结肿大是新感染的进一步迹象。 症状可能会从第一次出现时再次出现，但可能会非常严重。 在大多数情况下，由 HSV-1 引起的生殖器疱疹很少復发。 HSV-2 復发是典型的。 不过，即使再发，也没有第一次那么持久，而且随着时间的推移越来越好。

COVID-19 影响分析

单纯疱疹病毒感染是一种病毒感染，在整个大流行期间发病缓慢，但由于需要抗病毒药物和早期诊断和治疗而受到关注。 因此，在大流行期间，对单纯疱疹病毒治疗的需求略有增加。 此外，远程医疗的普及使得治疗疱疹感染变得更加容易，由于大流行导致交通限制，疱疹感染在社会上是孤立的。 因此，单纯疱疹病毒药物市场受益。 因此，市场将从受疫情影响的负增长中反弹，并在未来几年继续上涨。

市场增长因素

单纯疱疹病毒感染增加

随着患者寻求控制症状和降低感染风险的方法，随着性健康价值的提高，对 HSV 治疗的需求也在上升。 此外，发展中国家不断增加的医疗保健费用也使得 HSV 治疗等医疗保健服务更容易获得。 这改善了获得医疗保健的机会并增加了对 HSV 药物的需求。 因此，HSV 感染流行率的上升正在推动对治疗和药物的需求，这反过来又促进了单纯疱疹病毒治疗市场的增长。

HSV 测试和治疗剂的开发正在取得进展

许多教育活动促进了疾病和治疗方法知识的普及，使人们更容易接受诊断和治疗。 随着疱疹感染变得越来越广为人知，越来越多的人寻求治疗，从而增加了发达国家对有效治疗的需求。 此外，在欠发达国家和新兴国家，常见疱疹药物的供应量增加，促使市场进入者在这些地区提供更先进的治疗方法。 因此，所有这些因素都在推动未来几年的市场发展。

市场製约因素

最常用的疱疹药物的主要副作用

由于阿昔洛韦抑制治疗剂的使用，阿昔洛韦抗性 HSV 菌株的建立已成为一个问题。 这是有问题的，因为二线药物西多福韦和膦甲酸比阿昔洛韦毒性相对更大。 文献中有报导称，在接受阿昔洛韦长期抑制治疗的婴儿中出现了对阿昔洛韦耐药的单纯疱疹病毒。 另一项研究还描述了一名 10 天大的婴儿患有喉阿昔洛韦耐药 HSV。 因此，长期使用疱疹药物的副作用可能会阻碍未来几年的市场增长。

按类型划分的前景

单纯疱疹病毒治疗市场根据类型分为单纯疱疹病毒 1 型感染和单纯疱疹病毒 2 型感染。 2021 年，单纯疱疹病毒 2 型传染病领域在单纯疱疹病毒治疗市场取得了可观的增长率。 HSV-2 病例的增加可能是由于有 HSV-1 感染史的人再次感染 HSV-2 的风险增加。 因此，适当和及时的治疗很重要，因为它可以从母亲传染给胎儿。 公司也在创造新的治疗方法。 因此，由于研究的增加和这种疾病流行率的上升，预计该细分市场将在预测期内增长。

药物类型展望

根据药物类型，单纯疱疹病毒治疗市场分为阿昔洛韦、伐昔洛韦和泛昔洛韦。 到 2021 年，伐昔洛韦部分将在单纯疱疹病毒治疗市场中占据最大的收入份额。 该细分市场扩大的原因是 HSV 感染已广为人知，患者变得具有侵略性，例如寻求早期治疗。 由于其卓越的安全性，伐昔洛韦也更常用。 对伐昔洛韦的需求也在增加，因为它价格低廉且容易获得，可防止疱疹病毒在体内復制，并且可有效改善发病时的症状。

分销渠道展望

根据分销渠道，单纯疱疹病毒治疗市场分为医院药房、药店和零售药房以及在线供应商。 2021 年，药店和零售药店在单纯疱疹病毒治疗市场的收入份额最大。 药店和零售药店提供各种药物和治疗 HSV 感染的药物，包括抗病毒药物，据信有助于这一细分市场的增长。 这些药房的使用增加是由于治疗 HSV 的非处方药的现成可用性。

区域展望

按地区分析了北美、欧洲、亚太地区和 LAMEA 的单纯疱疹病毒治疗市场。 北美部分在 2021 年提高了单纯疱疹病毒治疗市场的最高收入份额。 该地区的大量龙头公司和单纯疱疹病毒药物製造技术的改进是该地区主要的市场驱动力。 此外，强大的医疗保健系统、高购买力以及越来越多地使用阿昔洛韦治疗单纯疱疹病毒感染，预计将推动市场的扩张。

内容

第一章市场范围与研究方法

  • 市场定义
  • 目的
  • 市场范围
  • 细分
    • 全球单纯疱疹病毒治疗市场：按药物类型分类
    • 全球单纯疱疹病毒治疗市场：按类型分类
    • 全球单纯疱疹病毒治疗市场：按分销渠道
    • 全球单纯疱疹病毒治疗市场：按地区
  • 调查方法

第 2 章市场概述

  • 介绍
    • 概览
      • 市场构成和情景
  • 影响市场的主要因素
    • 市场驱动力
    • 市场製约因素

第 3 章全球单纯疱疹病毒治疗市场：按药物类型分类

  • 全球伐昔洛韦市场：按地区
  • 全球阿昔洛韦市场：按地区
  • 全球泛昔洛韦市场：按地区

第 4 章全球单纯疱疹病毒治疗市场：按类型

  • 全球单纯疱疹病毒 1 型感染市场：按地区
  • 全球单纯疱疹病毒 2 型感染市场：按地区

第 5 章全球单纯疱疹病毒治疗市场：按分销渠道

  • 全球药店和零售药店市场，按地区
  • 全球医院药房市场：按地区
  • 全球在线药店市场：按地区

第 6 章全球单纯疱疹病毒治疗市场：按地区

  • 北美
    • 北美市场：按国家/地区分类
      • 美国
      • 加拿大
      • 墨西哥
      • 其他北美地区
  • 欧洲
    • 欧洲市场：按国家/地区分类
      • 德国
      • 英国
      • 法国
      • 俄罗斯
      • 西班牙
      • 意大利
      • 其他欧洲地区
  • 亚太地区
    • 亚太市场：按国家/地区分类
      • 中国
      • 日本
      • 印度
      • 韩国
      • 新加坡
      • 马来西亚
      • 其他亚太地区
  • 拉丁美洲/中东/非洲
    • 按国家/地区划分的拉丁美洲/中东/非洲市场
      • 巴西
      • 阿根廷
      • 阿拉伯联合酋长国
      • 沙特阿拉伯
      • 南非
      • 尼日利亚
      • 其他拉丁美洲/中东/非洲地区

第七章公司简介

  • Abbott Laboratories
  • Pfizer, Inc
  • Amneal Pharmaceuticals, Inc
  • GlaxoSmithKline PLC（GSK）
  • Teva Pharmaceutical Industries Ltd
  • Glenmark Pharmaceuticals Limited
  • Fresenius SE & Co KGaA
  • Novartis AG
  • Viatris, Inc
  • Emcure Pharmaceuticals Limited

The Global Herpes Simplex Virus Treatment Market size is expected to reach $2.1 billion by 2028, rising at a market growth of 3.0% CAGR during the forecast period.

Herpes simplex virus is a prevalent sexually transmitted infection (STI) that affects people. Herpes simplex virus type 1 (HSV-1) as well as herpes simplex virus type 2 (HSV-2) are the two types. Cold sores and oral herpes are frequently linked to HSV-1. Therefore, oral intercourse can potentially result in genital herpes. HSV-2 typically causes genital herpes and can also transmit oral herpes during oral intercourse. Both forms of herpes are extremely contagious and can be spread by touching an infected person's saliva or genital secretions.

Herpes severity and frequency are decreased by antiviral drugs like acyclovir, which prevent virus reproduction. The other medications, such as famciclovir and valacyclovir, suppress viral DNA synthesis, stopping the virus from reproducing and generating symptoms. There are many different formulations of these drugs, including topical ointments and oral pills. Since there is presently no effective treatment for HSV infection, the current therapies mainly aim to manage symptoms and lessen the frequency and intensity of outbreaks. However, because of the substantial medical need, this has created in the market for HSV therapies, new medicines are being developed, and there is a rising need for efficient treatments.

Although oral herpes is typically asymptomatic, it can occasionally cause painful blisters or ulcers in or around the mouth. In addition, before sores develop, infected people frequently feel a tingling, burning, or itchy feeling around their mouth. The frequency of these recurrences varies from individual to individual.

Many times, the moderate or asymptomatic symptoms of genital herpes can go unnoticed. One or more anal or genital ulcers or blisters are present when symptoms of genital herpes first appear. Fever, bodily aches, and enlarged lymph nodes are additional signs of a fresh infection. Symptoms can return after the first episode, though they can be quite severe. HSV-1-induced genital herpes seldom recurs in most cases. Recurrent symptoms of HSV-2 are typical. Recurrences, nevertheless, typically don't last as long as the initial episode and become milder over time.

COVID-19 Impact Analysis

Herpes simplex virus infections, which exhibited a moderate development throughout the pandemic, were among the viral infections brought to light by the COVID-19 pandemic due to the necessity of antiviral medications and the requirement for early diagnosis and treatment. Consequently, the demand for treating the herpes simplex virus increased somewhat during the pandemic. Additionally, telemedicine became more widely used, making it simpler for patients to get treatment for herpes infections due to the pandemic's restrictions on transportation and social isolation. The market for herpes simplex virus treatment benefited as a result. Therefore, the market will rise from the pandemic-influenced negative growth and continue to rise in the coming years.

Market Growth Factors

Increasing prevalence of herpes simplex virus infections

As patients look for ways to control their symptoms and lower the risk of transmission, there is a rising demand for HSV therapies as awareness of the value of sexual health grows. Also, healthcare services, like HSV treatment, are now more available due to increases in healthcare spending in developing nations. This has improved healthcare access and raised the demand for HSV treatments. Therefore the rising prevalence of HSV infection is propelling the demand for treatment and medication, which in turn is boosting the growth of the herpes simplex virus treatment market.

Rising development of HSV testing and medications

Numerous awareness programs have aided in increasing the knowledge about the disease as well as the availability of treatment methods, which in turn has facilitated the uptake of diagnosis and treatment. As herpes infections become more widely known, more individuals are coming forward and getting therapy, which increases the demand for efficient treatments in industrialized nations. Moreover, the increasing availability of common herpes medications in underdeveloped and developing nations has prompted market participants to provide more advanced medication in these regions. Hence, all these factors are propelling the development of the market in the coming years.

Market Restraining Factors

Prevalent side effects of most used herpes medications

The administration of suppressive acyclovir treatments has caused the establishment of acyclovir-resistant HSV strains. This is a problem because the second-line anti-herpes medications, cidofovir and foscarnet, are comparatively more toxic than acyclovir. One report in the literature describes the emergence of acyclovir-resistant HSV in a baby receiving long-term suppressive acyclovir treatment. In addition, a 10-day-old baby with acyclovir-resistant HSV in the larynx is described in another study. Therefore, the side effects of long-term usage of herpes medication may hamper the market's growth in the coming years.

Type Outlook

Based on type, the herpes simplex virus treatment market is categorized into herpes simplex virus-1 infection and herpes simplex virus-2 infection. The herpes simplex virus-2 infection segment procured a considerable growth rate in the herpes simplex virus treatment market in 2021. The rise in cases of HSV-2 infection can be ascribed to an elevated risk of HSV-2 reinfection in individuals with a previous HSV-1 infection. Therefore, appropriate and prompt therapy is crucial because the infection can pass from the mother to the fetus. In addition, businesses are creating novel treatments. Therefore, the segment will grow throughout the forecast period due to increased research into the disease and its rising prevalence.

Drug Type Outlook

On the basis of drug type, the herpes simplex virus treatment market is divided into acyclovir, valacyclovir, and famciclovir. The valacyclovir segment acquired the largest revenue share in the herpes simplex virus treatment market in 2021. HSV infections are becoming more widely known, and patients are acting more proactively by pursuing early treatment, which is why the segment is expanding. Additionally, valacyclovir is used more frequently because of its superior safety rating. The affordability, accessibility, and efficacy of valacyclovir in preventing the herpes virus from replicating in the body and thereby assisting in managing an outbreak's symptoms also increase its demand.

Distribution Channel Outlook

Based on distribution channel, the herpes simplex virus treatment market is segmented into hospital pharmacies, drug store & retail pharmacies, and online providers. The drug store and retail pharmacies segment witnessed the maximum revenue share in the herpes simplex virus treatment market in 2021. Drug shops and retail pharmacies offering a range of drugs and treatments for HSV infections, including antiviral drugs, are credited with the segment's growth. The growing usage of these pharmacies is owed to the simple availability of over-the-counter medications for treating HSV.

Regional Outlook

On the basis of region, the herpes simplex virus treatment market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the herpes simplex virus treatment market in 2021. Numerous influential companies and improvements in the region's herpes simplex virus treatment manufacturing technology are the main market drivers in the region. Additionally, a strong healthcare system, high purchasing power, as well as rising acyclovir use for treating herpes simplex virus infection are anticipated to fuel market expansion.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Pfizer, Inc., Amneal Pharmaceuticals, Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Glenmark Pharmaceuticals Limited, Fresenius SE & Co. KGaA, Novartis AG, Viatris, Inc., and Emcure Pharmaceuticals Limited.

Scope of the Study

Market Segments covered in the Report:

By Drug Type

  • Valacyclovir
  • Acyclovir
  • Famciclovir

By Type

  • Herpes simplex virus-1 Infection
  • Herpes simplex virus-2 Infection

By Distribution Channel

  • Drug Store & Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Abbott Laboratories
  • Pfizer, Inc.
  • Amneal Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC
  • Teva Pharmaceuticals Industries Ltd.
  • Glenmark Pharmaceuticals Limited
  • Fresenius SE & Co. KGaA
  • Novartis AG
  • Viatris, Inc.
  • Emcure Pharmaceuticals Limited

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Herpes Simplex Virus Treatment Market, by Drug Type
    • 1.4.2 Global Herpes Simplex Virus Treatment Market, by Type
    • 1.4.3 Global Herpes Simplex Virus Treatment Market, by Distribution Channel
    • 1.4.4 Global Herpes Simplex Virus Treatment Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Herpes Simplex Virus Treatment Market by Drug Type

  • 3.1 Global Valacyclovir Market by Region
  • 3.2 Global Acyclovir Market by Region
  • 3.3 Global Famciclovir Market by Region

Chapter 4. Global Herpes Simplex Virus Treatment Market by Type

  • 4.1 Global Herpes simplex virus-1 Infection Market by Region
  • 4.2 Global Herpes simplex virus-2 Infection Market by Region

Chapter 5. Global Herpes Simplex Virus Treatment Market by Distribution Channel

  • 5.1 Global Drug Store & Retail Pharmacies Market by Region
  • 5.2 Global Hospital Pharmacies Market by Region
  • 5.3 Global Online Pharmacies Market by Region

Chapter 6. Global Herpes Simplex Virus Treatment Market by Region

  • 6.1 North America Herpes Simplex Virus Treatment Market
    • 6.1.1 North America Herpes Simplex Virus Treatment Market by Drug Type
      • 6.1.1.1 North America Valacyclovir Market by Country
      • 6.1.1.2 North America Acyclovir Market by Country
      • 6.1.1.3 North America Famciclovir Market by Country
    • 6.1.2 North America Herpes Simplex Virus Treatment Market by Type
      • 6.1.2.1 North America Herpes simplex virus-1 Infection Market by Country
      • 6.1.2.2 North America Herpes simplex virus-2 Infection Market by Country
    • 6.1.3 North America Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.1.3.1 North America Drug Store & Retail Pharmacies Market by Country
      • 6.1.3.2 North America Hospital Pharmacies Market by Country
      • 6.1.3.3 North America Online Pharmacies Market by Country
    • 6.1.4 North America Herpes Simplex Virus Treatment Market by Country
      • 6.1.4.1 US Herpes Simplex Virus Treatment Market
        • 6.1.4.1.1 US Herpes Simplex Virus Treatment Market by Drug Type
        • 6.1.4.1.2 US Herpes Simplex Virus Treatment Market by Type
        • 6.1.4.1.3 US Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.1.4.2 Canada Herpes Simplex Virus Treatment Market
        • 6.1.4.2.1 Canada Herpes Simplex Virus Treatment Market by Drug Type
        • 6.1.4.2.2 Canada Herpes Simplex Virus Treatment Market by Type
        • 6.1.4.2.3 Canada Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.1.4.3 Mexico Herpes Simplex Virus Treatment Market
        • 6.1.4.3.1 Mexico Herpes Simplex Virus Treatment Market by Drug Type
        • 6.1.4.3.2 Mexico Herpes Simplex Virus Treatment Market by Type
        • 6.1.4.3.3 Mexico Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.1.4.4 Rest of North America Herpes Simplex Virus Treatment Market
        • 6.1.4.4.1 Rest of North America Herpes Simplex Virus Treatment Market by Drug Type
        • 6.1.4.4.2 Rest of North America Herpes Simplex Virus Treatment Market by Type
        • 6.1.4.4.3 Rest of North America Herpes Simplex Virus Treatment Market by Distribution Channel
  • 6.2 Europe Herpes Simplex Virus Treatment Market
    • 6.2.1 Europe Herpes Simplex Virus Treatment Market by Drug Type
      • 6.2.1.1 Europe Valacyclovir Market by Country
      • 6.2.1.2 Europe Acyclovir Market by Country
      • 6.2.1.3 Europe Famciclovir Market by Country
    • 6.2.2 Europe Herpes Simplex Virus Treatment Market by Type
      • 6.2.2.1 Europe Herpes simplex virus-1 Infection Market by Country
      • 6.2.2.2 Europe Herpes simplex virus-2 Infection Market by Country
    • 6.2.3 Europe Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.2.3.1 Europe Drug Store & Retail Pharmacies Market by Country
      • 6.2.3.2 Europe Hospital Pharmacies Market by Country
      • 6.2.3.3 Europe Online Pharmacies Market by Country
    • 6.2.4 Europe Herpes Simplex Virus Treatment Market by Country
      • 6.2.4.1 Germany Herpes Simplex Virus Treatment Market
        • 6.2.4.1.1 Germany Herpes Simplex Virus Treatment Market by Drug Type
        • 6.2.4.1.2 Germany Herpes Simplex Virus Treatment Market by Type
        • 6.2.4.1.3 Germany Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.2.4.2 UK Herpes Simplex Virus Treatment Market
        • 6.2.4.2.1 UK Herpes Simplex Virus Treatment Market by Drug Type
        • 6.2.4.2.2 UK Herpes Simplex Virus Treatment Market by Type
        • 6.2.4.2.3 UK Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.2.4.3 France Herpes Simplex Virus Treatment Market
        • 6.2.4.3.1 France Herpes Simplex Virus Treatment Market by Drug Type
        • 6.2.4.3.2 France Herpes Simplex Virus Treatment Market by Type
        • 6.2.4.3.3 France Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.2.4.4 Russia Herpes Simplex Virus Treatment Market
        • 6.2.4.4.1 Russia Herpes Simplex Virus Treatment Market by Drug Type
        • 6.2.4.4.2 Russia Herpes Simplex Virus Treatment Market by Type
        • 6.2.4.4.3 Russia Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.2.4.5 Spain Herpes Simplex Virus Treatment Market
        • 6.2.4.5.1 Spain Herpes Simplex Virus Treatment Market by Drug Type
        • 6.2.4.5.2 Spain Herpes Simplex Virus Treatment Market by Type
        • 6.2.4.5.3 Spain Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.2.4.6 Italy Herpes Simplex Virus Treatment Market
        • 6.2.4.6.1 Italy Herpes Simplex Virus Treatment Market by Drug Type
        • 6.2.4.6.2 Italy Herpes Simplex Virus Treatment Market by Type
        • 6.2.4.6.3 Italy Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.2.4.7 Rest of Europe Herpes Simplex Virus Treatment Market
        • 6.2.4.7.1 Rest of Europe Herpes Simplex Virus Treatment Market by Drug Type
        • 6.2.4.7.2 Rest of Europe Herpes Simplex Virus Treatment Market by Type
        • 6.2.4.7.3 Rest of Europe Herpes Simplex Virus Treatment Market by Distribution Channel
  • 6.3 Asia Pacific Herpes Simplex Virus Treatment Market
    • 6.3.1 Asia Pacific Herpes Simplex Virus Treatment Market by Drug Type
      • 6.3.1.1 Asia Pacific Valacyclovir Market by Country
      • 6.3.1.2 Asia Pacific Acyclovir Market by Country
      • 6.3.1.3 Asia Pacific Famciclovir Market by Country
    • 6.3.2 Asia Pacific Herpes Simplex Virus Treatment Market by Type
      • 6.3.2.1 Asia Pacific Herpes simplex virus-1 Infection Market by Country
      • 6.3.2.2 Asia Pacific Herpes simplex virus-2 Infection Market by Country
    • 6.3.3 Asia Pacific Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.3.3.1 Asia Pacific Drug Store & Retail Pharmacies Market by Country
      • 6.3.3.2 Asia Pacific Hospital Pharmacies Market by Country
      • 6.3.3.3 Asia Pacific Online Pharmacies Market by Country
    • 6.3.4 Asia Pacific Herpes Simplex Virus Treatment Market by Country
      • 6.3.4.1 China Herpes Simplex Virus Treatment Market
        • 6.3.4.1.1 China Herpes Simplex Virus Treatment Market by Drug Type
        • 6.3.4.1.2 China Herpes Simplex Virus Treatment Market by Type
        • 6.3.4.1.3 China Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.3.4.2 Japan Herpes Simplex Virus Treatment Market
        • 6.3.4.2.1 Japan Herpes Simplex Virus Treatment Market by Drug Type
        • 6.3.4.2.2 Japan Herpes Simplex Virus Treatment Market by Type
        • 6.3.4.2.3 Japan Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.3.4.3 India Herpes Simplex Virus Treatment Market
        • 6.3.4.3.1 India Herpes Simplex Virus Treatment Market by Drug Type
        • 6.3.4.3.2 India Herpes Simplex Virus Treatment Market by Type
        • 6.3.4.3.3 India Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.3.4.4 South Korea Herpes Simplex Virus Treatment Market
        • 6.3.4.4.1 South Korea Herpes Simplex Virus Treatment Market by Drug Type
        • 6.3.4.4.2 South Korea Herpes Simplex Virus Treatment Market by Type
        • 6.3.4.4.3 South Korea Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.3.4.5 Singapore Herpes Simplex Virus Treatment Market
        • 6.3.4.5.1 Singapore Herpes Simplex Virus Treatment Market by Drug Type
        • 6.3.4.5.2 Singapore Herpes Simplex Virus Treatment Market by Type
        • 6.3.4.5.3 Singapore Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.3.4.6 Malaysia Herpes Simplex Virus Treatment Market
        • 6.3.4.6.1 Malaysia Herpes Simplex Virus Treatment Market by Drug Type
        • 6.3.4.6.2 Malaysia Herpes Simplex Virus Treatment Market by Type
        • 6.3.4.6.3 Malaysia Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.3.4.7 Rest of Asia Pacific Herpes Simplex Virus Treatment Market
        • 6.3.4.7.1 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Drug Type
        • 6.3.4.7.2 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Type
        • 6.3.4.7.3 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Distribution Channel
  • 6.4 LAMEA Herpes Simplex Virus Treatment Market
    • 6.4.1 LAMEA Herpes Simplex Virus Treatment Market by Drug Type
      • 6.4.1.1 LAMEA Valacyclovir Market by Country
      • 6.4.1.2 LAMEA Acyclovir Market by Country
      • 6.4.1.3 LAMEA Famciclovir Market by Country
    • 6.4.2 LAMEA Herpes Simplex Virus Treatment Market by Type
      • 6.4.2.1 LAMEA Herpes simplex virus-1 Infection Market by Country
      • 6.4.2.2 LAMEA Herpes simplex virus-2 Infection Market by Country
    • 6.4.3 LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.4.3.1 LAMEA Drug Store & Retail Pharmacies Market by Country
      • 6.4.3.2 LAMEA Hospital Pharmacies Market by Country
      • 6.4.3.3 LAMEA Online Pharmacies Market by Country
    • 6.4.4 LAMEA Herpes Simplex Virus Treatment Market by Country
      • 6.4.4.1 Brazil Herpes Simplex Virus Treatment Market
        • 6.4.4.1.1 Brazil Herpes Simplex Virus Treatment Market by Drug Type
        • 6.4.4.1.2 Brazil Herpes Simplex Virus Treatment Market by Type
        • 6.4.4.1.3 Brazil Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.4.4.2 Argentina Herpes Simplex Virus Treatment Market
        • 6.4.4.2.1 Argentina Herpes Simplex Virus Treatment Market by Drug Type
        • 6.4.4.2.2 Argentina Herpes Simplex Virus Treatment Market by Type
        • 6.4.4.2.3 Argentina Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.4.4.3 UAE Herpes Simplex Virus Treatment Market
        • 6.4.4.3.1 UAE Herpes Simplex Virus Treatment Market by Drug Type
        • 6.4.4.3.2 UAE Herpes Simplex Virus Treatment Market by Type
        • 6.4.4.3.3 UAE Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.4.4.4 Saudi Arabia Herpes Simplex Virus Treatment Market
        • 6.4.4.4.1 Saudi Arabia Herpes Simplex Virus Treatment Market by Drug Type
        • 6.4.4.4.2 Saudi Arabia Herpes Simplex Virus Treatment Market by Type
        • 6.4.4.4.3 Saudi Arabia Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.4.4.5 South Africa Herpes Simplex Virus Treatment Market
        • 6.4.4.5.1 South Africa Herpes Simplex Virus Treatment Market by Drug Type
        • 6.4.4.5.2 South Africa Herpes Simplex Virus Treatment Market by Type
        • 6.4.4.5.3 South Africa Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.4.4.6 Nigeria Herpes Simplex Virus Treatment Market
        • 6.4.4.6.1 Nigeria Herpes Simplex Virus Treatment Market by Drug Type
        • 6.4.4.6.2 Nigeria Herpes Simplex Virus Treatment Market by Type
        • 6.4.4.6.3 Nigeria Herpes Simplex Virus Treatment Market by Distribution Channel
      • 6.4.4.7 Rest of LAMEA Herpes Simplex Virus Treatment Market
        • 6.4.4.7.1 Rest of LAMEA Herpes Simplex Virus Treatment Market by Drug Type
        • 6.4.4.7.2 Rest of LAMEA Herpes Simplex Virus Treatment Market by Type
        • 6.4.4.7.3 Rest of LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel

Chapter 7. Company Profiles

  • 7.1 Abbott Laboratories
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
    • 7.1.5 SWOT Analysis
  • 7.2 Pfizer, Inc.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional & Segmental Analysis
    • 7.2.4 Research & Development Expense
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Partnerships, Collaborations, and Agreements:
  • 7.3 Amneal Pharmaceuticals, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental Analysis
    • 7.3.4 Research & Development Expenses
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Approvals and Trials:
  • 7.4 GlaxoSmithKline PLC (GSK)
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
    • 7.4.5 Recent strategies and developments:
      • 7.4.5.1 Approvals and Trials:
  • 7.5 Teva Pharmaceutical Industries Ltd.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Regional Analysis
    • 7.5.4 Research & Development Expenses
  • 7.6 Glenmark Pharmaceuticals Limited
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Regional Analysis
    • 7.6.4 Research & Development Expenses
  • 7.7 Fresenius SE & Co. KGaA
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expenses
  • 7.8 Novartis AG
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expense
  • 7.9 Viatris, Inc.
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental Analysis
    • 7.9.4 Research & Development Expense
  • 7.10. Emcure Pharmaceuticals Limited
    • 7.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 2 Global Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 3 Global Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 4 Global Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 5 Global Valacyclovir Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Valacyclovir Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Acyclovir Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Acyclovir Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Famciclovir Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Famciclovir Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 12 Global Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 13 Global Herpes simplex virus-1 Infection Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Herpes simplex virus-1 Infection Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Herpes simplex virus-2 Infection Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Herpes simplex virus-2 Infection Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 18 Global Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 19 Global Drug Store & Retail Pharmacies Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Drug Store & Retail Pharmacies Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Hospital Pharmacies Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Hospital Pharmacies Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Online Pharmacies Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Online Pharmacies Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Herpes Simplex Virus Treatment Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Herpes Simplex Virus Treatment Market by Region, 2022 - 2028, USD Million
  • TABLE 27 North America Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 28 North America Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 29 North America Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 30 North America Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 31 North America Valacyclovir Market by Country, 2018 - 2021, USD Million
  • TABLE 32 North America Valacyclovir Market by Country, 2022 - 2028, USD Million
  • TABLE 33 North America Acyclovir Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Acyclovir Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Famciclovir Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Famciclovir Market by Country, 2022 - 2028, USD Million
  • TABLE 37 North America Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 38 North America Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 39 North America Herpes simplex virus-1 Infection Market by Country, 2018 - 2021, USD Million
  • TABLE 40 North America Herpes simplex virus-1 Infection Market by Country, 2022 - 2028, USD Million
  • TABLE 41 North America Herpes simplex virus-2 Infection Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Herpes simplex virus-2 Infection Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 44 North America Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 45 North America Drug Store & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Drug Store & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 49 North America Online Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 50 North America Online Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 51 North America Herpes Simplex Virus Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Herpes Simplex Virus Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 53 US Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 54 US Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 55 US Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 56 US Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 57 US Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 58 US Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 59 US Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 60 US Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 61 Canada Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 62 Canada Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 63 Canada Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 64 Canada Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 65 Canada Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 66 Canada Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 67 Canada Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 68 Canada Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 69 Mexico Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 70 Mexico Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 71 Mexico Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 72 Mexico Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 73 Mexico Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 74 Mexico Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 75 Mexico Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 76 Mexico Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 77 Rest of North America Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 78 Rest of North America Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 79 Rest of North America Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 80 Rest of North America Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 81 Rest of North America Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 82 Rest of North America Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 83 Rest of North America Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 84 Rest of North America Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 85 Europe Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 86 Europe Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 87 Europe Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 88 Europe Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 89 Europe Valacyclovir Market by Country, 2018 - 2021, USD Million
  • TABLE 90 Europe Valacyclovir Market by Country, 2022 - 2028, USD Million
  • TABLE 91 Europe Acyclovir Market by Country, 2018 - 2021, USD Million
  • TABLE 92 Europe Acyclovir Market by Country, 2022 - 2028, USD Million
  • TABLE 93 Europe Famciclovir Market by Country, 2018 - 2021, USD Million
  • TABLE 94 Europe Famciclovir Market by Country, 2022 - 2028, USD Million
  • TABLE 95 Europe Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 96 Europe Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 97 Europe Herpes simplex virus-1 Infection Market by Country, 2018 - 2021, USD Million
  • TABLE 98 Europe Herpes simplex virus-1 Infection Market by Country, 2022 - 2028, USD Million
  • TABLE 99 Europe Herpes simplex virus-2 Infection Market by Country, 2018 - 2021, USD Million
  • TABLE 100 Europe Herpes simplex virus-2 Infection Market by Country, 2022 - 2028, USD Million
  • TABLE 101 Europe Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 102 Europe Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 103 Europe Drug Store & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 104 Europe Drug Store & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 105 Europe Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 106 Europe Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 107 Europe Online Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 108 Europe Online Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 109 Europe Herpes Simplex Virus Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 110 Europe Herpes Simplex Virus Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 111 Germany Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 112 Germany Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 113 Germany Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 114 Germany Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 115 Germany Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 116 Germany Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 117 Germany Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 118 Germany Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 119 UK Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 120 UK Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 121 UK Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 122 UK Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 123 UK Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 124 UK Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 125 UK Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 126 UK Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 127 France Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 128 France Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 129 France Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 130 France Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 131 France Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 132 France Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 133 France Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 134 France Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 135 Russia Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 136 Russia Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 137 Russia Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 138 Russia Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 139 Russia Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 140 Russia Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 141 Russia Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 142 Russia Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 143 Spain Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 144 Spain Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 145 Spain Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 146 Spain Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 147 Spain Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 148 Spain Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 149 Spain Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 150 Spain Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 151 Italy Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 152 Italy Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 153 Italy Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 154 Italy Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 155 Italy Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 156 Italy Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 157 Italy Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 158 Italy Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 159 Rest of Europe Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 160 Rest of Europe Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 161 Rest of Europe Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 162 Rest of Europe Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 163 Rest of Europe Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 164 Rest of Europe Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 165 Rest of Europe Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 166 Rest of Europe Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 167 Asia Pacific Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 168 Asia Pacific Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 169 Asia Pacific Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 170 Asia Pacific Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 171 Asia Pacific Valacyclovir Market by Country, 2018 - 2021, USD Million
  • TABLE 172 Asia Pacific Valacyclovir Market by Country, 2022 - 2028, USD Million
  • TABLE 173 Asia Pacific Acyclovir Market by Country, 2018 - 2021, USD Million
  • TABLE 174 Asia Pacific Acyclovir Market by Country, 2022 - 2028, USD Million
  • TABLE 175 Asia Pacific Famciclovir Market by Country, 2018 - 2021, USD Million
  • TABLE 176 Asia Pacific Famciclovir Market by Country, 2022 - 2028, USD Million
  • TABLE 177 Asia Pacific Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 178 Asia Pacific Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 179 Asia Pacific Herpes simplex virus-1 Infection Market by Country, 2018 - 2021, USD Million
  • TABLE 180 Asia Pacific Herpes simplex virus-1 Infection Market by Country, 2022 - 2028, USD Million
  • TABLE 181 Asia Pacific Herpes simplex virus-2 Infection Market by Country, 2018 - 2021, USD Million
  • TABLE 182 Asia Pacific Herpes simplex virus-2 Infection Market by Country, 2022 - 2028, USD Million
  • TABLE 183 Asia Pacific Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 184 Asia Pacific Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 185 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 186 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 187 Asia Pacific Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 188 Asia Pacific Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 189 Asia Pacific Online Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 190 Asia Pacific Online Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 191 Asia Pacific Herpes Simplex Virus Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 192 Asia Pacific Herpes Simplex Virus Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 193 China Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 194 China Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 195 China Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 196 China Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 197 China Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 198 China Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 199 China Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 200 China Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 201 Japan Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 202 Japan Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 203 Japan Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 204 Japan Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 205 Japan Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 206 Japan Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 207 Japan Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 208 Japan Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 209 India Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 210 India Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 211 India Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 212 India Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 213 India Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 214 India Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 215 India Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 216 India Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 217 South Korea Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 218 South Korea Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 219 South Korea Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 220 South Korea Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 221 South Korea Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 222 South Korea Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 223 South Korea Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 224 South Korea Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 225 Singapore Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 226 Singapore Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 227 Singapore Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 228 Singapore Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 229 Singapore Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 230 Singapore Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 231 Singapore Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 232 Singapore Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 233 Malaysia Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 234 Malaysia Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 235 Malaysia Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 236 Malaysia Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 237 Malaysia Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 238 Malaysia Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 239 Malaysia Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 240 Malaysia Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 241 Rest of Asia Pacific Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 242 Rest of Asia Pacific Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 243 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 244 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 245 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 246 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 247 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 248 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 249 LAMEA Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 250 LAMEA Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 251 LAMEA Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 252 LAMEA Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 253 LAMEA Valacyclovir Market by Country, 2018 - 2021, USD Million
  • TABLE 254 LAMEA Valacyclovir Market by Country, 2022 - 2028, USD Million
  • TABLE 255 LAMEA Acyclovir Market by Country, 2018 - 2021, USD Million
  • TABLE 256 LAMEA Acyclovir Market by Country, 2022 - 2028, USD Million
  • TABLE 257 LAMEA Famciclovir Market by Country, 2018 - 2021, USD Million
  • TABLE 258 LAMEA Famciclovir Market by Country, 2022 - 2028, USD Million
  • TABLE 259 LAMEA Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 260 LAMEA Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 261 LAMEA Herpes simplex virus-1 Infection Market by Country, 2018 - 2021, USD Million
  • TABLE 262 LAMEA Herpes simplex virus-1 Infection Market by Country, 2022 - 2028, USD Million
  • TABLE 263 LAMEA Herpes simplex virus-2 Infection Market by Country, 2018 - 2021, USD Million
  • TABLE 264 LAMEA Herpes simplex virus-2 Infection Market by Country, 2022 - 2028, USD Million
  • TABLE 265 LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 266 LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 267 LAMEA Drug Store & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 268 LAMEA Drug Store & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 269 LAMEA Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 270 LAMEA Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 271 LAMEA Online Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 272 LAMEA Online Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 273 LAMEA Herpes Simplex Virus Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 274 LAMEA Herpes Simplex Virus Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 275 Brazil Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 276 Brazil Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 277 Brazil Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 278 Brazil Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 279 Brazil Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 280 Brazil Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 281 Brazil Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 282 Brazil Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 283 Argentina Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 284 Argentina Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 285 Argentina Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 286 Argentina Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 287 Argentina Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 288 Argentina Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 289 Argentina Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 290 Argentina Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 291 UAE Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 292 UAE Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 293 UAE Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 294 UAE Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 295 UAE Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 296 UAE Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 297 UAE Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 298 UAE Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 299 Saudi Arabia Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 300 Saudi Arabia Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 301 Saudi Arabia Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 302 Saudi Arabia Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 303 Saudi Arabia Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 304 Saudi Arabia Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 305 Saudi Arabia Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 306 Saudi Arabia Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 307 South Africa Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 308 South Africa Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 309 South Africa Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 310 South Africa Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 311 South Africa Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 312 South Africa Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 313 South Africa Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 314 South Africa Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 315 Nigeria Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 316 Nigeria Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 317 Nigeria Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 318 Nigeria Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 319 Nigeria Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 320 Nigeria Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 321 Nigeria Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 322 Nigeria Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 323 Rest of LAMEA Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
  • TABLE 324 Rest of LAMEA Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
  • TABLE 325 Rest of LAMEA Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 326 Rest of LAMEA Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 327 Rest of LAMEA Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
  • TABLE 328 Rest of LAMEA Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
  • TABLE 329 Rest of LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 330 Rest of LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 331 Key Information - Abbott Laboratories
  • TABLE 332 Key Information - Pfizer, Inc.
  • TABLE 333 Key Information - Amneal Pharmaceuticals, INc.
  • TABLE 334 Key Information - GlaxoSmithKline PLC
  • TABLE 335 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 336 Key Information - Glenmark Pharmaceuticals Limited
  • TABLE 337 key information - Fresenius SE & Co. KGaA
  • TABLE 338 Key Information - Novartis AG
  • TABLE 339 key information - Viatris, Inc.
  • TABLE 340 Key Information - Emcure Pharmaceuticals Limited

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Herpes Simplex Virus Treatment Market share by Drug Type, 2021
  • FIG 3 Global Herpes Simplex Virus Treatment Market share by Drug Type, 2028
  • FIG 4 Global Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2028, USD Million
  • FIG 5 Global Herpes Simplex Virus Treatment Market share by Type, 2021
  • FIG 6 Global Herpes Simplex Virus Treatment Market share by Type, 2028
  • FIG 7 Global Herpes Simplex Virus Treatment Market by Type, 2018 - 2028, USD Million
  • FIG 8 Global Herpes Simplex Virus Treatment Market share by Distribution Channel, 2021
  • FIG 9 Global Herpes Simplex Virus Treatment Market share by Distribution Channel, 2028
  • FIG 10 Global Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2028, USD Million
  • FIG 11 Global Herpes Simplex Virus Treatment Market share by Region, 2021
  • FIG 12 Global Herpes Simplex Virus Treatment Market share by Region, 2028
  • FIG 13 Global Herpes Simplex Virus Treatment Market by Region, 2018 - 2028, USD Million
  • FIG 14 Swot analysis: Abbott laboratories